Search filters

List of works by Elena Garralda

A Phase 1 Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

scientific article published on 16 October 2018

Agnostic-Histology Approval of New Drugs in Oncology: Are We Already There?

scientific article published on 22 January 2019

Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria

scientific article published on 22 November 2019

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

scientific article

Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

scientific article

Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer

scientific article published on 01 January 2019

Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

scientific article published on 01 October 2019

Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of anti-angiogenic therapies.

scientific article published on 27 March 2018

First-in-human phase I study of single-agent vanucizumab, a first-in-class bi-specific anti-Ang-2/anti-VEGF antibody, in adult patients with advanced solid tumors

scientific article published on 7 December 2017

Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment

scientific article

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

scientific article published on 11 June 2019

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

scientific article

New clinical trial designs in the era of precision medicine

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology

scientific article published on January 2017

Precision Targeted Therapy With BLU-667 for RET-Driven Cancers.

scientific article published on 15 April 2018